Tylenol Ad Warns Of Undetected Aspirin Damage To Stomach
This article was originally published in The Tan Sheet
Executive Summary
New marketing for McNeil's Tylenol highlights the potential for aspirin-related gastrointestinal injury that may go unnoticed by the consumer
You may also be interested in...
FDA’s Ganley “Disappointed” By Competitive Pain Reliever Marketing
FDA OTC head Charles Ganley, MD, chastised OTC pain reliever marketers for airing comparative DTC ads in the wake of COX-2 safety concerns during a speech May 6 at the Consumer Healthcare Products Association Regulatory & Scientific Conference in Washington, D.C
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands